These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27279153)

  • 21. Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.
    Avallone A; Di Gennaro E; Silvestro L; Iaffaioli VR; Budillon A
    Expert Opin Drug Saf; 2014 Jan; 13(1):113-29. PubMed ID: 24093908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage.
    Lincoln DW; Hrushesky WJ; Wood PA
    Int J Cancer; 2000 Nov; 88(3):479-85. PubMed ID: 11054680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines.
    Borges LJH; Bull ÉS; Fernandes C; Horn A; Azeredo NF; Resende JALC; Freitas WR; Carvalho ECQ; Lemos LS; Jerdy H; Kanashiro MM
    Eur J Med Chem; 2016 Nov; 123():128-140. PubMed ID: 27474929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
    Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
    BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of fluorinated pyrimidines in Japan].
    Taguchi T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):10-8. PubMed ID: 8422172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin B6 and cancer (review).
    Tryfiates GP; Morris HP; Sonidis GP
    Anticancer Res; 1981; 1(5):263-7. PubMed ID: 7049053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics of folate-related drug targets in cancer treatment.
    Robien K; Boynton A; Ulrich CM
    Pharmacogenomics; 2005 Oct; 6(7):673-89. PubMed ID: 16207145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target.
    Muhammad LA; Saad F
    Expert Rev Anticancer Ther; 2015; 15(9):1049-61. PubMed ID: 26313417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
    Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
    Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity.
    Ruchelman AL; Singh SK; Ray A; Wu X; Yang JM; Zhou N; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2004 Feb; 12(4):795-806. PubMed ID: 14759740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding.
    Cardinale D; Salo-Ahen OM; Guaitoli G; Ferrari S; Venturelli A; Franchini S; Battini R; Ponterini G; Wade RC; Costi MP
    Protein Eng Des Sel; 2010 Feb; 23(2):81-9. PubMed ID: 19955218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Floxuridine Oligonucleotide Conjugates Carrying Potential Enhancers of Cellular Uptake.
    Aviñó A; Clua A; Bleda MJ; Eritja R; Fàbrega C
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parallel G-quadruplex Structures Increase Cellular Uptake and Cytotoxicity of 5-Fluoro-2'-deoxyuridine Oligomers in 5-Fluorouracil Resistant Cells.
    Clua A; Fàbrega C; García-Chica J; Grijalvo S; Eritja R
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33804620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with
    Haber AO; Jain A; Mani C; Nevler A; Agostini LC; Golan T; Palle K; Yeo CJ; Gmeiner WH; Brody JR
    Mol Cancer Res; 2021 Apr; 19(4):565-572. PubMed ID: 33593942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
    Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
    Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine.
    Gmeiner WH
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoropyrimidine Modulation of the Anti-Tumor Immune Response-Prospects for Improved Colorectal Cancer Treatment.
    Gmeiner WH
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy.
    García-Fernández C; Fornaguera C; Borrós S
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.